Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Diseases With Secondary ITP”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)UnknownNCT05369377
What this trial is testing

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 150
Not applicableUnknownNCT06093529
What this trial is testing

Immune Markers in Pediatric ITP on Second Line Therapy

Who this might be right for
ITP - Immune Thrombocytopenia
Assiut University 42
Not applicableNot Yet RecruitingNCT07182760
What this trial is testing

Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenic PurpuraAmegakaryocytic AplasiaUnilineage Myelodysplastic Syndrome ( Megakaryocyte Dysplasia)+2 more
Assiut University 100
Not applicableEnded earlyNCT04904276
What this trial is testing

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Who this might be right for
ITPImmune Thrombocytopenia
Rigel Pharmaceuticals 16
Not applicableUnknownNCT04735588
What this trial is testing

Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

Who this might be right for
Immune ThrombocytopeniaITPCovid19+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 140